4 results on '"Bouffler, Simon"'
Search Results
2. In vitro study of radiosensitivity in colorectal cancer cell lines associated with Lynch syndrome.
- Author
-
Mingzhu Sun, Moquet, Jayne, Barnard, Stephen, Mancey, Hannah, Burling, David, Baldwin-Cleland, Rachel, Monahan, Kevin, Latchford, Andrew, Lloyd, David, Bouffler, Simon, Badie, Christophe, Anyamene, Nicola A., and Ainsbury, Elizabeth
- Published
- 2024
- Full Text
- View/download PDF
3. Radiotherapy for non-cancer diseases: benefits and long-term risks.
- Author
-
Thariat, Juliette, Little, Mark P., Zablotska, Lydia B., Samson, Pamela, O'Banion, M. Kerry, Leuraud, Klervi, Bergom, Carmen, Girault, Gilles, Azimzadeh, Omid, Bouffler, Simon, and Hamada, Nobuyuki
- Subjects
VENTRICULAR tachycardia ,COVID-19 ,ALZHEIMER'S disease ,OSTEOARTHRITIS ,RADIOTHERAPY - Abstract
The discovery of X-rays was followed by a variety of attempts to treat infectious diseases and various other non-cancer diseases with ionizing radiation, in addition to cancer. There has been a recent resurgence of interest in the use of such radiotherapy for non-cancer diseases. Non-cancer diseases for which use of radiotherapy has currently been proposed include refractory ventricular tachycardia, neurodegenerative diseases (e.g. Alzheimer's disease and dementia), and Coronavirus Disease 2019 (COVID-19) pneumonia, all with ongoing clinical studies that deliver radiation doses of 0.5–25 Gy in a single fraction or in multiple daily fractions. In addition to such non-cancer effects, historical indications predominantly used in some countries (e.g. Germany) include osteoarthritis and degenerative diseases of the bones and joints. This narrative review gives an overview of the biological rationale and ongoing preclinical and clinical studies for radiotherapy proposed for various non-cancer diseases, discusses the plausibility of the proposed biological rationale, and considers the long-term radiation risks of cancer and non-cancer diseases. A growing body of evidence has suggested that radiation represents a double-edged sword, not only for cancer, but also for non-cancer diseases. At present, clinical evidence has shown some beneficial effects of radiotherapy for ventricular tachycardia, but there is little or no such evidence of radiotherapy for other newly proposed non-cancer diseases (e.g. Alzheimer's disease, COVID-19 pneumonia). Patients with ventricular tachycardia and COVID-19 pneumonia have thus far been treated with radiotherapy when they are an urgent life threat with no efficient alternative treatment, but some survivors may encounter a paradoxical situation where patients were rescued by radiotherapy but then get harmed by radiotherapy. Further studies are needed to justify the clinical use of radiotherapy for non-cancer diseases, and optimize dose to diseased tissue while minimizing dose to healthy tissue. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. In vitro study of radiosensitivity in colorectal cancer cell lines associated with Lynch syndrome.
- Author
-
Sun M, Moquet J, Barnard S, Mancey H, Burling D, Baldwin-Cleland R, Monahan K, Latchford A, Lloyd D, Bouffler S, Badie C, Anyamene NA, and Ainsbury E
- Subjects
- Humans, Pilot Projects, Cell Line, Radiation Tolerance, Colorectal Neoplasms, Hereditary Nonpolyposis genetics, Colorectal Neoplasms genetics, Colorectal Neoplasms drug therapy, Brain Neoplasms, Neoplastic Syndromes, Hereditary
- Abstract
Introduction: Lynch syndrome patients have an inherited predisposition to cancer due to a deficiency in DNA mismatch repair (MMR) genes which could lead to a higher risk of developing cancer if exposed to ionizing radiation. This pilot study aims to reveal the association between MMR deficiency and radiosensitivity at both a CT relevant low dose (20 mGy) and a therapeutic higher dose (2 Gy)., Methods: Human colorectal cancer cell lines with (dMMR) or without MMR deficiency (pMMR) were analyzed before and after exposure to radiation using cellular and cytogenetic analyses i.e., clonogenic assay to determine cell reproductive death; sister chromatid exchange (SCE) assay to detect the exchange of DNA between sister chromatids; γH2AX assay to analyze DNA damage repair; and apoptosis analysis to compare cell death response. The advantages and limitations of these assays were assessed in vitro , and their applicability and feasibility investigated for their potential to be used for further studies using clinical samples., Results: Results from the clonogenic assay indicated that the pMMR cell line (HT29) was significantly more radio-resistant than the dMMR cell lines (HCT116, SW48, and LoVo) after 2 Gy X-irradiation. Both cell type and radiation dose had a significant effect on the yield of SCEs/chromosome. When the yield of SCEs/chromosome for the irradiated samples (2 Gy) was normalized against the controls, no significant difference was observed between the cell lines. For the γH2AX assay, 0, 20 mGy and 2 Gy were examined at post-exposure time points of 30 min (min), 4 and 24 h (h). Statistical analysis revealed that HT29 was only significantly more radio-resistant than the MLH1 -deficient cells lines, but not the MSH2 -deficient cell line. Apoptosis analysis (4 Gy) revealed that HT29 was significantly more radio-resistant than HCT116 albeit with very few apoptotic cells observed., Discussion: Overall, this study showed radio-resistance of the MMR proficient cell line in some assays, but not in the others. All methods used within this study have been validated; however, due to the limitations associated with cancer cell lines, the next step will be to use these assays in clinical samples in an effort to understand the biological and mechanistic effects of radiation in Lynch patients as well as the health implications., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Sun, Moquet, Barnard, Mancey, Burling, Baldwin-Cleland, Monahan, Latchford, Lloyd, Bouffler, Badie, Anyamene and Ainsbury.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.